Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

por Uppendahl, Locke D., Dahl, Carly M., Miller, Jeffrey S., Felices, Martin, Geller, Melissa A.
Publicado 2018

Ultrasound-guided subcostal transversus abdominis plane block with liposomal bupivacaine compared to bupivacaine infiltration for patients undergoing robotic-assisted and laparosco...

por Hutchins, Jacob, Argenta, Peter, Berg, Aaron, Habeck, Jason, Kaizer, Alexander, Geller, Melissa A
Publicado 2019

Differences in Family Planning and Fertility Among Female and Male Gynecologic Oncologists

por Song, Mihae, Tessier, Katelyn, Jensen, Jani, Leonard, Phoebe, Geller, Melissa A., Teoh, Deanna
Publicado 2021

Long term follow-up of a phase II trial of multimodal therapy given in a “sandwich” method for stage III, IV, and recurrent endometrial cancer

por Glasgow, Michelle, Vogel, Rachel Isaksson, Burgart, Jennifer, Argenta, Peter, Dusenbery, Kathryn, Geller, Melissa A.
Publicado 2016

A qualitative study of barriers to genetic counseling and potential for mobile technology education among women with ovarian cancer

por Vogel, Rachel Isaksson, Niendorf, Kristin, Lee, Heewon, Petzel, Sue, Lee, Hee Yun, Geller, Melissa A.
Publicado 2018

A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer

por Vallera, Daniel A., Oh, Felix, Kodal, Behiye, Hinderlie, Peter, Geller, Melissa A., Miller, Jeffrey S., Felices, Martin
Publicado 2021

A multiplex platform for the identification of ovarian cancer biomarkers

por Boylan, Kristin L. M., Geschwind, Kate, Koopmeiners, Joseph S., Geller, Melissa A., Starr, Timothy K., Skubitz, Amy P. N.
Publicado 2017

Reverse Translation Identifies the Synergistic Role of Immune Checkpoint Blockade and IL15 to Enhance Immunotherapy of Ovarian Cancer

por Felices, Martin, Wesley, Erin, Bendzick, Laura E., Kodal, Behiye, Hopps, Rachel, Grzywacz, Bartosz, Hinderlie, Peter, Miller, Jeffrey S., Geller, Melissa A.
Publicado 2023

A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics

por Boylan, Kristin LM, Afiuni-Zadeh, Somaieh, Geller, Melissa A, Hickey, Kayla, Griffin, Timothy J, Pambuccian, Stefan E, Skubitz, Amy PN
Publicado 2014

Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteom...

por Boylan, Kristin L. M., Afiuni-Zadeh, Somaieh, Geller, Melissa A., Argenta, Peter A., Griffin, Timothy J., Skubitz, Amy P. N.
Publicado 2021

Prevalence of active cytomegalovirus infection at diagnosis of ovarian cancer and during chemotherapy and subsequent changes in cognitive functioning

por Vogel, Rachel I., Stenzel, Ashley E., Lee, Heewon, Hunter-Schlichting, DeVon, Wesley, Erin, Uppendahl, Locke D., Geller, Melissa A., Nelson, Heather H.
Publicado 2023

Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells

por Desir, Snider, Dickson, Elizabeth L., Vogel, Rachel I., Thayanithy, Venugopal, Wong, Phillip, Teoh, Deanna, Geller, Melissa A., Steer, Clifford J., Subramanian, Subbaya, Lou, Emil
Publicado 2016

Gene expression markers of Tumor Infiltrating Leukocytes

por Danaher, Patrick, Warren, Sarah, Dennis, Lucas, D’Amico, Leonard, White, Andrew, Disis, Mary L., Geller, Melissa A., Odunsi, Kunle, Beechem, Joseph, Fling, Steven P.
Publicado 2017

TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity

por Kaminski, Michael F, Bendzick, Laura, Hopps, Rachel, Kauffman, Marissa, Kodal, Behiye, Soignier, Yvette, Hinderlie, Peter, Walker, Joshua T, Lenvik, Todd R, Geller, Melissa A, Miller, Jeffrey S, Felices, Martin
Publicado 2022

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

por Andersen, John D, Boylan, Kristin LM, Jemmerson, Ronald, Geller, Melissa A, Misemer, Benjamin, Harrington, Katherine M, Weivoda, Starchild, Witthuhn, Bruce A, Argenta, Peter, Vogel, Rachel Isaksson, Skubitz, Amy PN
Publicado 2010

Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy

por Rosato, Pamela C., Wijeyesinghe, Sathi, Stolley, J. Michael, Nelson, Christine E., Davis, Rachel L., Manlove, Luke S., Pennell, Christopher A., Blazar, Bruce R., Chen, Clark C., Geller, Melissa A., Vezys, Vaiva, Masopust, David
Publicado 2019

Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study

por Lou, Emil, Vogel, Rachel I., Hoostal, Spencer, Wong, Phillip, Grad, Aaron, Monu, Minnu, Łukaszewski, Tomasz, Deshpande, Jaai, Dickson, Elizabeth L., Klein, Molly, Linden, Michael A., Subramanian, Subbaya, Teoh, Deanna, Geller, Melissa A.
Publicado 2019

NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo

por Vallera, Daniel A., Ferrone, Soldano, Kodal, Behiye, Hinderlie, Peter, Bendzick, Laura, Ettestad, Brianna, Hallstrom, Caroline, Zorko, Nicholas A., Rao, Arpit, Fujioka, Naomi, Ryan, Charles J., Geller, Melissa A., Miller, Jeffrey S., Felices, Martin
Publicado 2020

Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer

por Boylan, Kristin L. M., Petersen, Ashley, Starr, Timothy K., Pu, Xuan, Geller, Melissa A., Bast, Robert C., Lu, Karen H., Cavallaro, Ugo, Connolly, Denise C., Elias, Kevin M., Cramer, Daniel W., Pejovic, Tanja, Skubitz, Amy P. N.
Publicado 2022

Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation

por Yang, Jianbo, Liao, Qianjin, Price, Matthew, Moriarity, Branden, Wolf, Natalie, Felices, Martin, Miller, Jeffrey S., Geller, Melissa A., Bendzick, Laura, Hopps, Rachel, Starr, Timothy K., O'Connor, Christine H., Tarullo, Sarah, Nelson, Andrew C., Turley, Eva, Wang, Jing, McCarthy, James B.
Publicado 2021